These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1907432)

  • 1. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis.
    Sloth-Nielsen J; Guldager B; Mouritzen C; Lund EB; Egeblad M; Nørregaard O; Jørgensen SJ; Jelnes R
    Am J Surg; 1991 Aug; 162(2):122-5. PubMed ID: 1907432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EDTA treatment of intermittent claudication--a double-blind, placebo-controlled study.
    Guldager B; Jelnes R; Jørgensen SJ; Nielsen JS; Klaerke A; Mogensen K; Larsen KE; Reimer E; Holm J; Ottesen S
    J Intern Med; 1992 Mar; 231(3):261-7. PubMed ID: 1556523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial.
    van Rij AM; Solomon C; Packer SG; Hopkins WG
    Circulation; 1994 Sep; 90(3):1194-9. PubMed ID: 8087928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disodium-ethylene diamine tetraacetic acid (EDTA) has no effect on blood lipids in atherosclerotic patients. A randomized, placebo-controlled study.
    Guldager B; Faergeman O; Jørgensen SJ; Nexø E; Jelnes R
    Dan Med Bull; 1993 Nov; 40(5):625-7. PubMed ID: 8299405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EDTA treatment of arteriosclerosis. Bias or manipulation?].
    Jørgensen SJ; Guldager B; Jelnes R
    Ugeskr Laeger; 1992 Jun; 154(23):1645-6. PubMed ID: 1632000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of ticlopidine on lower limb blood flow, ankle/brachial index and symptoms in peripheral arteriosclerosis. A double-blind study. The STIMS Group in Lund. Swedish Ticlopidine Multicenter Study.
    Fagher B
    Angiology; 1994 Sep; 45(9):777-88. PubMed ID: 8092543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL; Cutler BS; Meissner MH; Strandness DE
    Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelation therapy for intermittent claudication: a double-blind, randomized, controlled trial.
    Lyngdorf P; Guldager B; Holm J; Jørgensen SJ; Jelnes R
    Circulation; 1996 Jan; 93(2):395-6. PubMed ID: 8548917
    [No Abstract]   [Full Text] [Related]  

  • 9. EDTA chelation as a treatment of arteriosclerosis.
    Godfrey ME
    N Z Med J; 1990 Apr; 103(887):162-3. PubMed ID: 2111528
    [No Abstract]   [Full Text] [Related]  

  • 10. [EDTA in the treatment of arteriosclerosis].
    Mikaelsen PM
    Tidsskr Nor Laegeforen; 1995 Apr; 115(11):1392-3. PubMed ID: 7770839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
    Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A
    Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EDTA versus placebo treatment in intermittent claudication. A double-blind, randomized trial].
    Guldager B; Jelnes R; Jørgensen SJ; Sloth-Nielsen J; Klaerke A; Mogensen K; Larsen KE; Madsen BL; Holm J; Ottesen S
    Ugeskr Laeger; 1992 Jun; 154(23):1618-21. PubMed ID: 1631994
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized placebo-controlled, double-blind trial of ketanserin in treatment of intermittent claudication.
    Walden R; Bass A; Rabi I; Adar R
    J Cardiovasc Surg (Torino); 1991; 32(6):737-40. PubMed ID: 1752890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chelation therapy.
    Chappell LT; Miranda R; Rubin M; Carter JP; Trowbridge J
    Circulation; 1995 Sep; 92(5):1350-2. PubMed ID: 7648687
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
    Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal shockwave therapy for intermittent claudication: Medium-term outcomes from a double-blind randomised placebo-controlled pilot trial.
    Green JL; Harwood AE; Smith GE; Das T; Raza A; Cayton T; Wallace T; Carradice D; Chetter IC
    Vascular; 2018 Oct; 26(5):531-539. PubMed ID: 29722640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover.
    Guldager B; Brixen KT; Jørgensen SJ; Nielsen HK; Mosekilde L; Jelnes R
    Dan Med Bull; 1993 Nov; 40(5):627-30. PubMed ID: 8299406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of EDTA chelation therapy.
    Jonas WB
    Circulation; 1995 Sep; 92(5):1352. PubMed ID: 7648688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.